Liposomal delivery of antisense oligonucleotides; Liposomal delivery of antimicrobial agents towards resistant bacterial pathogens; Liposomal formulations of drugs and vaccine for oral delivery
Dr. Abdel Omri obtained his PhD from Université de Montréal in 1996. After completing postdoctoral fellowships at McGill University and the University of Toronto (1996-1998), he spent more than 2 years as Research associate at NRC (institute of biological sciences in Ottawa) from 1998 to 2000. He is currently Full Professor in the Department of Chemistry and Biochemistry with a cross appointment to the Department of Biology, the Biomolecular Sciences PhD Programme, School of Rural and Northern Health PhD Programme. His research interests are focused on Lipid-based drug and vaccine delivery systems. His laboratory employs a multi-disciplinary approach to addressing the antimicrobial resistance to gram negative bacteria in cystic fibrosis patients and in medical devices implants. He is also involved in the education of undergraduate and graduate students through the coordination of several calendar courses in biochemistry, pharmacology and toxicology and pharmaceutical technology. In addition to research, Dr. Omri is actively involved in the research training of both undergraduate and graduate students. He has served in administrative capacities in several international scientific societies. He has published over 50 peer-reviewed research articles over his career on various aspects of drug delivery and targeting in addition to several published book chapters and books (2). He has served on a number of Editorial Boards and Granting Agencies in Canada and abroad. Dr. Omri has 2 patents.
ALAIN L. FYMAT
International Institute of Medicine and Science
Nanomedicine and nanooncology and related nanobiotechnology, and the epigenetics/ecogenetics of disease.
Alain L. Fymat is a medical-physical scientist and an educator who was educated at the Universities of Bordeaux and Paris-Sorbonne, France, and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, both Institutes located in Rancho Mirage, California, U.S.A. He was formerly Professor of Radiation Oncology, Radiology, Radiological Sciences, and Physics at several U.S. and European Universities (University of California at Los Angeles, University of Southern California, and Loma Linda University, California; University of Lille, France). Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of the Radiology Service, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Charles R. Drew University of Medicine and Science in Los Angeles, California. He has extensively published (much in excess of 300 scholarly publications including patents, books & monographs, book chapters, refereed articles). He is also Editor of the International Journal of Nanobiotechnology (an open PubMed Journal) and Honorable Editor of the Journal of Cancer Prevention and Current Research (an open MedCrave Journal).
Parimal C Sen
Biochemical aspects of various transport enzymes e.g. Na+ ,K +-ATPase, Ca2+,Mg 2+-ATPase, Ca2+-ATPase etc and their interactions with different drugs (contraceptive and amphiphilic) and lipids in natural and model membranes; fluorescence behaviour of enzymes and how their function/activity are affected under various experimental (e.g. drug induced) conditions ; mechanism of regulation of transport enzymes by protein kinase (through phosphorylation), phosphatase (through dephosphorylation), endogenous stimulator and/or inhibitor proteins.
Professor Parimal C. Sen, received his M.Sc. degree in Organic Chemistry and Ph.D. in Analytical Chemistry from Calcutta University (India); Post Doctoral training in Enzymology at State University of New York and University of Minnesota, USA. Joined Bose Institute in the Department of Chemistry in December 1983. Served as Chairman in the Department of Chemistry for five years and in Microbiology Department for two years. Founder Head, Division of Molecular Medicine, Bose Institute and served for six years. Acting Director for five years and Dean of Studies for four years. Visiting Professor at Cornell University from 1989-1991. At present Senior Professor and National Academy of Sciences (India) Platinum Jubilee Senior Scientist in the Division of Molecular Medicine, Bose Institute, Kolkata, India. Fellow of the National Academy of Sciences (F.N.A.Sc.), India and the West Bengal Academy of Science and Technology (WBAST). Recipients of Prof. P.B. Sen Oration Award from the Physiological Society of India, Prof. P.A.Kurup Endowment Award from the Society of Biological Chemists and Prof. R.C.Shah Memorial Award from Indian Science Congress Association. Published almost one hundred papers in Internationally high impact journals. Major research interest: drug – protein and protein-protein interactions and their role in the regulation of ion transporting enzymes and protein kinases (cell signaling) under different pathophysiological conditions. The latest work involve in searching for low molecular weight synthetic compounds as anticancer agent(s) based on cell culture, animal and human experiments.
university of bialystok
nanomedicine ,Magnetic nanoparticles as DDS, biotechnology, recombinant proteins - plasma gelsolin in critically ill patients, cell biology systems (procoagulant activity of platelets, inflammatory response).
The University of Texas MD Anderson Cancer Center
Nanomedicine; Cancer nanotechnology; Pharmaceutical, environmental and bio-medical fields using diverse state-of-the-art techniques; Nano-Imaging; Targeted Nano Gene/siRNA/microRNA/Drug Delivery; Targeted Nano Radio-sensitizer and Regenerative Medicine
Dr. Bhattarai is a Nanomedicine and Cancer Nanotechnology Scientist and working as a Faculty in Department of Experimental Radiation Oncology at The University of Texas MD Anderson Cancer Center, Houston. He received doctorate degree in Bio-Chemical Engineering in 2007. Before joining to MD Anderson Cancer Center at Houston, He was a postdoctoral fellow in Wayne State University, Immunology and Vaccine Development, Children’s Hospital Oakland Research Institute, Lawrence Berkeley National Lab and Department of Bioengineering, University of California, Berkeley
National Central University
Application of metal nanoparticles in various fields,Application of Boron containing carbon nanoparticles as Lewis acid catalysts, Biotechnology, Synthesis and characterization of Ru(II) and Ir(II) complxes
Md. Zakir Hossain
North Carolina Central University
BioNanomedicine; Cancer BioNanotechnology; Bio-Pharmaceutical; Medical Diagnostics; siRNA/microRNA; Biosensors
Dr. Hossain is a Bio Nanomedicine and Cancer Nanotechnology interdisciplinary scientist. He is current working as a Faculty in Department of Pharmaceutical Sciences, Bio-manufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, USA. He received doctorate degree in Applied Biosciences are of Cancer Bio-Nanotechnology from University of Arkansas at Little Rock, USA. Dr. Hossain also earned three Master’s degree from USA: M.S. in Applied Biosciences, M.S. in Integrated Sciences and Mathematics, 2012 (Major in Biology and Chemistry), UALR and an M. Engr. in Biological and Agricultural Engineering from University of Idaho. His research interests are focused on Bio Nanomedicine, Cancer Bio Nanotechnology; Bio-Pharmaceutical, Medical Diagnostics, siRNA/microRNA and Biosensors. His laboratory employs a multi-disciplinary approach. He has served on a number of journal Editorial Boards.
University of East Anglia
Nanoscience; Chemistry; Nanotechnology
Yimin Chao was appointed as a Senior Lecturer in the School of Chemistry at UEA on the basis of an established track record in investigating nanostructured systems from the basic physical and chemical mechanisms of synthesis, through their optical and electronic properties to scientific and industrial applications. He has a wide range of experiences in synthesis of nanoscale materials, electronic and optical spectroscopy and UHV techniques, using synchrotron and lab-based radiation to characterise novel nanoscale materials. Various types of functionalized silicon quantum dots (SiQDs) have been developed in Chao lab with both top down and bottom up methods, including alkylated, poly-acrylic acid grafted, amine terminated, and sugar conjugated SiQDs. Most recent achievement is a bottom up method to produce SiQDs with various carbon chain lengths via micelle reduction. This method is providing a better pathway to control the size and functionalization of SiQDs. Since 2001, he has published over 50 papers in leading international refereed journals and presented his results in more than 30 international conferences. His publications have been cited more than 500 times with h index 14. Funding from the Royal Society/Wolfson Foundation and the University enabled the setting up of the UEA Energy Materials Laboratory of which Chao is Associate Director. He is a member of the EPSRC SolarCap consortium which is working on solar fuels, and a member of British Society for Nanomedicine.
University of Sussex
Powder technology; Particle engineering (micro/nano); Dissolution enhancement; Dry powder inhalers; Oral delivery; Controlled release formulations; Pharmaceutical formulations; Solid state analysis; Transdermal delivery
Ali obtained his pharmacy degree (PharmD) in 1989 from Tabriz School of Pharmacy, Iran. He completed his PhD on Pharmaceutical Technology at John Moores University, Liverpool in 1996 and has been a qualified pharmacist since 1989.He held a lectureship (1997 - 2001), and senior lectureship (2001 - 2003) at the School of Pharmacy, Tabriz University of Medical Sciences. During this period he was head of postgraduate studies and also vice-dean for research for a period of 4 years in Tabriz School of Pharmacy. In 2003 he was appointed as lecturer of pharmaceutics at King’s College London, Department of Pharmacy. He worked as professor of Pharmaceutical Technology at Tabriz School of Pharmacy prior to this appointment as senior lecturer of Pharmaceutics at Medway School of Pharmacy. He has been promoted to Reader in 2013 and now he is a Professor in Pharmaceutics and Drug Delivery at The University of Sussex, School of Life Sciences, Pharmacy section. He has supervised over 120 Mpharm, PharmD, MSc project students and 15 PhD postgraduate students at several institutions in various fields of pharmaceutical technology. He has 3 patents on nanoparticles and skin enhancers. He is a regular reviewer for many international pharmacy journals and editorial board of several journals in pharmaceutical sciences. He has published a significant number of manuscripts (over 170 research articles in peer-reviewed international pharmacy journals ) on various fields of pharmaceutics, mainly, tableting, particle engineering, inhalation, skin delivery, controlled-release and nano formulations. In addition, he published 5 book chapters (2010-2014) and a book on pulmonary drug delivery. He holds H-index of 33 with over 3000 citations till December 2015.
Institute for Chemical-Physical Processes
Soft Interactions in Nanostructured Colloidal Systems, laser Light/X-rays/Neutron Scattering Spectroscopy includes Instrumental Developments activities, Soft Interaction in Nanostructured Material and Supramolecular Aggregates.
D. Lombardois a research group leader at the Istituto per i Processi Chimico-Fisici (Messina) of the CNR (Consiglio Nazionale delle Ricerche) and responsible of the following CNR ResearchActivities: - Study of Soft Interactions in Nanostructured Colloidal Systems - Smart Nano-objects for Alteration of Lipid bilayers (SNAL) laser Light/X-rays/Neutron Scattering Spectroscopy includes Instrumental Developments activities during his work as a Beamline Scientist (SAXS experimental stations) at European Synchrotron Facilties (LURE in Orsay-Paris [France] and ELETTRA in Trieste [Italy]). His (theoretical and experimental) Research Activity focuses on the following three main topics: - Study of the Soft Interaction in Nanostructured Material and Supramolecular Aggregates. - Modeling of Structural and Dynamic Properties in Polymers, Dendrimers and Lipid Bio-Membranes in Solution. - Study of the Self-Assembly Processes in Organic-Inorganic Ibrid Materials (Zeolite Synthesis on Nanocolloids).
Khalid Mujasam Batoo
King Abdullah Institute for Nanotechnology
Magnetic nanomaterials, Spintronics, Superconductivity, Multiferroic and Magnetoelectric Materials, Magnetic multilayer’s (MTJs as GMR), Magnetic layered double hydroxide (MLDH), Solar cells, Graphene technology.
Universita degli Studi di MESSINA
light scattering, infrared absorption, neutron scattering, etc
S. Magazu is full professor in Experimental Physics since 2002 at the Facolta di Scienze MM.FF.NN. of Messina University. Furthermore, Prof. S. Magazu has been chairman of the Scientific College of "Liquids and Disordered Systems" of the European Synchrotron Radiation Facility ESRF (Grenoble, France) is president of the Inter-University Consortium Applied Physics (CISFA) and of the International Consortium COSMO has been member of the Scientific College of "Structure and Dynamics of Liquids and Glasses" facility of neutron scattering Institut Max von Laue - Paul Langevin (ILL, Grenoble, France), from December 17-2009 to 2010 he was member of the Scientific College of "Liquids and Disordered Systems" of the European Synchrotron Radiation Facility ESRF (Grenoble, France)
Farid A Dorkoosh
Tehran University of Medical Sciences
Development, formulation and designing novel drug delivery systems; Nanotechnology; Peptide & Gene delivery; Biotechnology of peptides and natural products; Formulation of pharmaceutical dosage forms.
Farid A. Dorkoosh: received his Pharm.D. From Tehran Azad University in Iran in 1995 and he became the 3rd students of his year. After following two years of military service and acting as hospital pharmacist, he started his PhD in Leiden University in the Netherlands and he was awarded his Ph.D. in pharmaceutics and biopharmaceutics from Leiden University in 2002. He could publish 10 research articles and got two patents from his PhD research project. Thereafter, he followed an international training on intellectual property and management of innovation at World Intellectual Property Organization (WIPO) in Geneva, Switzerland in 2005. He also received his diploma in management from Chartered Management Institute of London, United Kingdom in 2009. He is currently an associate professor at Tehran University of Medical Sciences. He serves both in the pharmaceutics group and in the Pharmacoeconomy and pharmaceutical management group in the Faculty of Pharmacy where more than 30 Pharm.D students and 10 PhD students performed their thesis under his supervision. He is also an active member of Medical Biomaterials Research Center. Moreover, he started the patent office of Tehran University from 2009 and he serves as the director of patent office of Tehran University of Medical Sciences till now. His solid scientific and technical knowledge with respect to developing new business activities is well recognized internationally; he focuses on enhancing high-throughput research activities for developing novel drug delivery systems. He has more than 80 research articles and ten patents and patent applications.His current research areas are: novel drug delivery systems, gene and peptide and protein delivery, biopolymers and biomaterial application in drug delivery and nanotechnology. He has been as an invited speaker in various International conferences and workshops. He has been also as an editorial board of various journals such as “Drug Delivery and Translational Research”, “Drug Delivery Letters” and served as Chief Editor of two new established journals of “Nanomedicine Research Journal” and “Journal of Pharmacoeconomy and Pharmaceutical Management”. He was honored to receive the 2001 CRS/Capsugel graduate award for outstanding research in peroral peptide drug delivery from the CRS Young Investigator Award Committee in San Diego, CA, U.S.A., in June 2001. He has also received the Pharmaceutical Technology and Drug Delivery graduate award from the American Association of Pharmaceutical Scientists for outstanding Ph.D. research in peroral peptide drug delivery (Toronto, Canada, 2002). He was a member of the CRS Education Committee from 2004 to 2008 and was chairman of this committee in 2008. He became chairman of the CRS Young Scientist Committee in 2009. He is currently the board member of Controlled Release Society of Iran and also the board member of Nanomedicine Society of Iran.
Indian Institute of Engineering Science and Technology
Nano medicine, Solid lipid nano particles; Biopolymer; Natural biodegradable polymers; Polymers based Nanoparticles CNT and graphene based delivery system
Dr.S.Duraviel, Professor of Pharmaceutics, he is the founder Principal of the Program on the Pharmacy department at SGT University. He holds degrees in pharmaceutical Sciences from the Madras Medical College, Master of Pharmacy (Pharmaceutics) from Institute of Technology, Banaras Hindu University Varanasi and earned his Ph.D. from the University College of Pharmaceutical Sciences, Kakatiya University, Warangal. During his professional career, he was member of various professional bodies. He was Senate member The T N Dr. MGR Medical University and ratified principal of Jawarlal Nehru Technological University, Hyderabad, Kakatiya University Warangal. He is serving as Professor of Pharmacy, B S Anangpuria Institute of Pharmacy, Faridabad, his experience in academic and administrative services started from 1996 to up till now. He received the UGC Award scholarship by qualifying GATE ’95 scored 95.67 percentile. He also carried out AICTE sponsored research project and research collaboration with Silpakorn University, Bangkok Thailand. He has chaired Scientific Organizing Committee member of 3rd International Conference and exhibition on Pharmacovigilance and Clinical Trials sponsored by OMICS going to held at Hyderabad on 27th October 2014. He is having vast experience in conducting Seminars and conference to update the knowledge among the Pharmacy students like National Seminar on Herbal Drug and Drug Industries at Jayamukhi Institute of Pharmaceutical Sciences. Organizing secretary AICTE sponsored National Seminar on Biostatistics in Pharmaceutical Industry and National Seminar on Advances in Drug delivery system at Nirma College of Pharmacy. He has given guest lecture on Recent Trends in Phytopharmaceutics at AICTE sponsored 4th National Conference on Recent Trends in Industrial Pharacognosy – 2015.
V K Jindal
Condensed Matter Physics, Nanotechnology, Carbon Nanotubes, Fullerenes and graphene
Professor Jindal has served at Panjab University Chandigarh for about 4 decades and retired as Coordinator Nanoscience & Nanotechnology and Professor of Physics in 2015. He is an Emeritus now and honorary Professor in Bio-Nano at Guru Jambeshwar University of Science & Technology, Hisar. Professor Jindal completed his Ph.D in 1977 on condensed matter Physics from Panjab University and spent several years as postdoc research starting early 1980 in Germany as AvH Fellow, in Italy (in 1986) as TWAS fellow and in USA (in 1995)as Fulbright Fellow. He has been making successive short visits till last year in Germany on revisit research visits. He has supervised 15 Ph.D students and published nearly 200 research articles. He has widely served on several national committees for research funding and selection committees. He is well travelled and given seminars and talks in various parts of the world.
Sharanabasava V Ganachari
KLE Technological University
Green chemistry; green nanotechnology; materials chemistry; bio nano composites; green synthesis of nanoparticles; conducting polymers; and applications i.e. biological (Antimicrobial; Antifungal; Antibacterial; Anti-cancer; Artificial bone); sensors (Piezo; Chemical vapors; Hazardous gases etc.); Water purification; Hybrid Photovoltaic Cells and Agricultural applications
Sharanabasava V Ganachari was born in 1983. He got his Master’s degree (Materials Science) from Gulbarga University in 2008. He completed his Ph.D. from Gulbarga University in 2013 in the area of Nanoscience and Nanotechnology. During his Ph.D. He was awarded with Project Fellowship from University Grants Commission; the one most prestigious government funding organization in country. Later he joined as a Lecturer (Chemistry) in SSBR & SSM Degree College Shahabad India. He is currently working as a Research Scientist & Assistant Professor in Centre for Material Science, Advanced research in Nanoscience and Nanotechnology, KLE Technological University, (Formerly known as B. V. Bhoomaraddi College of Engineering & Technology) Hubballi, Karnataka, INDIA since November, 2014. He has more than 20 peer reviewed research articles and a co-inventor in a two patents, awarded Dr. A. P. J. Abdul Kalam Best Young Scientist in 2015-16, Fellow of Bose Science Society and Fellow of International Safety Quality Environment Management Association, Editorial board member for 6prestigious journals& reviewer. His research area of interest is in green chemistry, green nanotechnology, materials chemistry, bio nano composites, green synthesis of nanoparticles, conducting polymers, and applications i.e. biological (Antimicrobial, Antifungal, Antibacterial, Anti-cancer, Artificial bone), sensors (Piezo, Chemical vapors, Hazardous gasesetc.),Water purification, Hybrid Photovoltaic Cells and Agricultural applications.
Norma A. Rangel-Vázquez
Nanotechnology applied to controlled drug delivery systems. In particular, skin, diabetes mellitus, cancer, antifungical, Design and preparation of oral solid (tablets and capsules) dosage forms, Analysis of drugs in pure forms, formulations and biological matrices, Bioadhesive drug delivery systems, especially hydrogels, polymers, biopolymers and IPNs, respectively. Beside of green energies and composites for aerospace industry.
Norma-Aurea Rangel-Vàzquez realized in 2007 the research of Polyurethane Porous/Hydroxyapatite for Biomedical Applications: Synthesis and Characterization for the degree of PhD in Polymers Science (Mexico). Later, she carried out a postdoctoral study using computational modeling. To date, She has have published several papers in journals indexed in the Web of Science - Journal Citation Reports and in other journals, 2 books and chapters book (Wiley, CRC-Press Taylor, ELSEVIER and Science Publishing), memories of national and international congress. She has served as a reviewer for different journals such as: Journal of Applied Polymer Science, Materials Letters, Carbohydrate Polymers, Journal Polymer Engineering & Science, Thermochimica Acta, Journal of Molecular Structure, Journal of Surface and Coatings Technology, Academic Journal of Agricultural Research, World Journal of Engineering and Physical Sciences (WJEPS), Annual Research & Review in Biology, Journal of Applied Physical Science International, Global Conference on Polymer and Composite Materials 2015 and International Journal of Nanomedicine. She is leader of project of controlled release of antifungical with the participation of 14 countries. She is on the Editorial Board Member of several journals including, Journal of Pharmaceutics & Drug Development, Material Science and Engineering with Advanced Research, Journal of Nanomedicine Research, Nanomedicine Research Journal and Chemistry Journal.